EXCIPIENTS SOLD AS INGREDIENT

Brand Owner Address Description
ACCELON BASF AS Lilleakerveien 2 C Oslo 0283 Norway Excipients sold as an ingredient of dietary and nutritional supplements; excipients sold as an ingredient of dietary and nutritional supplements for endurance sports; excipients sold as an ingredient of medicinal oils; excipients sold as an ingredient of dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; excipients sold as an ingredient of biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic substances, namely, omega-3 concentrate adapted for medical use; excipients sold as an ingredient of nutritional supplements adapted for medical use; excipients sold as an ingredient of nutritional supplements; excipients sold as an ingredient of food supplements for medical purposes;Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplements;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.